Results 261 to 270 of about 3,264,242 (368)

The Future of the Psychiatrist

Psychiatric Research and Clinical Practice, EarlyView.
Objective The American Psychiatric Association (APA) issued a 2023 report on the future of psychiatry, focusing on how the organization should position itself in relation to coming developments over the next 10 years. Here, we follow up with a discussion of how the psychiatrist's role needs to evolve to adapt to the changes ahead.
James B. Potash, Alex McClanahan, Jay Davidson, William Butler, Nathan Carroll, Anne Ruble, Mary Yaden, Darlene King, John Torous, Peter P. Zandi, Katherine G. Kennedy, Thomas E. Smith, Arpan Waghray, Robert Trestman, Marketa Wills   +14 more
wiley   +1 more source

Editorial: Drug repurposing for cancer treatment: current and future directions. [PDF]

Front Oncol
Lampros M, Vlachos N, Lianos GD, Bali C, Alexiou GA.   +4 more
europepmc   +1 more source

Neuropharniacological effects of penfluridol, a new antipsychotic agent

, 1975
Keizo Ito, Seiichi Nurimoto, Yukitsuka Kudo, Ryuichi Ishida   +3 more
openalex   +1 more source

Psychotropic Drugs for Older Adults With Psychiatric Disorders Presenting to the Emergency Department: Prescription Patterns and Treatment Outcomes

Psychiatric Research and Clinical Practice, EarlyView.
Objective A high proportion of patients presenting to Emergency Departments (EDs) consists of vulnerable elderly people. Mental illnesses are frequently related to advancing age, with difficult to detect symptoms. The aim of this study was to investigate psychiatric drug use by geriatric patients in an ED for whom a psychiatric consultation was needed,
Marianna Mazza, Marcello Covino, Francesco Maria Lisci, Caterina Brisi, Georgios D. Kotzalidis, Giuseppe Marano, Francesca Abate, Maria Benedetta Anesini, Gianluca Boggio, Michele Ciliberto, Valeria De Masi, Cecilia Falsini, Ester Maria Marzo, Sara Rossi, Maria Chiara Spera, Alberto Torresi, Benedetta Simeoni, Francesco Franceschi, Gabriele Sani   +18 more
wiley   +1 more source

Functional Analysis of Antipsychotics in Human iPSC-Based Neural Progenitor 2D and 3D Schizophrenia Models. [PDF]

Int J Mol Sci
Farkas KG, Vincze K, Tordai C, Özgen Eİ, Gürler D, Deli V, Lilienberg J, Erdei Z, Sarkadi B, Réthelyi JM, Apáti Á.   +10 more
europepmc   +1 more source

Therapeutic Targeting of the α7 Nicotinic Receptor: Challenges and Prospects for Cognitive Improvement in Alzheimer's and Schizophrenia

Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 1, July 2025.
ABSTRACT The α7 nicotinic acetylcholine receptor (α7 nAChR) has emerged as a key target for treating cognitive dysfunction in neurological disorders such as Alzheimer's disease (AD) and schizophrenia. α7 nAChRs play essential roles in neurotransmission, neuroinflammation and synaptic plasticity, not only in neurons but also in glial cells, where they ...
Janus H. Magnussen
wiley   +1 more source

Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts. [PDF]

World Psychiatry
Tiihonen J, Tanskanen A, Mittendorfer-Rutz E, Howes OD, Correll CU, Siskind D, Taipale H.   +6 more
europepmc   +1 more source

Effects of Perospirone, a Novel Antipsychotic Agent, on the Dopaminergic Neurons in the Rat Ventral Tegmental Area

, 1997
Hongjing Yu, Kumatoshi Ishihara, Hiroaki Matsubayashi, Taku Amano, Masashi Sasa   +4 more
openalex   +1 more source

Real‐World Complexity of Prescribing Cascades

Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 1, July 2025.
ABSTRACT Prescribing cascades occur when an adverse drug reaction (ADR) to one medication is treated with additional medication. Most literature focusses on this simplistic singular concept of one medication followed by another. However, ADRs in clinical practice may appear less straightforward, making prescribing cascades difficult to identify and ...
J. T. H. Nielen, K. van der Walle, S. H. Spronk, F. J. H. Magdelijns, P. Denig, F. Karapinar‐Çarkıt   +5 more
wiley   +1 more source